trial · primary record
Androgen Therapy
Castration-Sensitive Prostate Carcinoma
| Phase | Phase 3 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 1260 |
| Primary completion | 2039-05-08 |
| Primary endpoint | Overall survival (OS) |
| Registry ID | NCT06931340 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-04T03:54:53.267Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT06931340
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.